Bank of New York Mellon Corp decreased its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 7.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,375,408 shares of the company's stock after selling 103,198 shares during the period. Bank of New York Mellon Corp owned approximately 0.56% of Oscar Health worth $18,485,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in OSCR. Wealth Enhancement Advisory Services LLC increased its position in shares of Oscar Health by 7.5% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company's stock worth $255,000 after acquiring an additional 844 shares in the last quarter. US Bancorp DE increased its position in shares of Oscar Health by 115.9% during the third quarter. US Bancorp DE now owns 24,784 shares of the company's stock worth $526,000 after acquiring an additional 13,305 shares in the last quarter. Janney Montgomery Scott LLC bought a new stake in shares of Oscar Health during the third quarter worth $988,000. State of New Jersey Common Pension Fund D boosted its holdings in Oscar Health by 18.9% during the third quarter. State of New Jersey Common Pension Fund D now owns 109,590 shares of the company's stock worth $2,324,000 after purchasing an additional 17,427 shares during the last quarter. Finally, Los Angeles Capital Management LLC acquired a new position in Oscar Health during the third quarter worth $627,000. Institutional investors own 75.70% of the company's stock.
Analysts Set New Price Targets
Separately, Jefferies Financial Group began coverage on shares of Oscar Health in a report on Tuesday, December 10th. They set an "underperform" rating and a $12.00 target price for the company. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $21.56.
Read Our Latest Analysis on Oscar Health
Oscar Health Stock Performance
Shares of OSCR stock opened at $14.69 on Wednesday. The stock has a market cap of $3.68 billion, a P/E ratio of -733.88 and a beta of 1.75. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The company has a fifty day moving average price of $15.23 and a two-hundred day moving average price of $16.47. Oscar Health, Inc. has a one year low of $12.43 and a one year high of $23.79.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, equities analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current year.
Oscar Health Company Profile
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.